More Globe Newswire

View Older Stories View Newer Stories

Apr 7, 2025 08:00AM INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Elastic N.V. and Certain Officers – ESTC
Apr 7, 2025 08:00AM ONCAP Announces Final Close for ONCAP V
Apr 7, 2025 07:59AM Dimensional Fund Advisors Ltd. : Form 8.3 - ENQUEST PLC - Ordinary Shares
Apr 7, 2025 08:00AM ASML reports transactions under its current share buyback program
Apr 7, 2025 08:00AM STMicroelectronics Announces Status of Common Share Repurchase Program
Apr 7, 2025 08:00AM BitMEX Unveils Enhanced BMEX Token Utility with Increased Staking Rewards and Lower Trading Fees
Apr 7, 2025 08:00AM JDE Peet’s share buyback periodic update April 7, 2025
Apr 7, 2025 08:00AM Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States
Apr 7, 2025 08:00AM Michelin: 2024 UNIVERSAL REGISTRATION DOCUMENT
Apr 7, 2025 08:00AM LGI Homes Opens New Community in Orlando Area
Apr 7, 2025 07:59AM Libraries Offering Brain Exercises Can Become Centers for Brain Health
Apr 7, 2025 07:45AM Dundee Precious Metals Annual and Special Meeting of Shareholders to be held May 7, 2025
Apr 7, 2025 07:42AM Transactions In Connection with Share Buy-back Program
Apr 7, 2025 07:42AM Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 04 04 2025] - (CGWL)
Apr 7, 2025 07:31AM ALERT: Grabar Law Office Investigates Claims on Behalf of Shareholders of Axsome Therapeutics, Inc. (NASDAQ: AXSM); BioVie Inc. (NASDAQ: BIVI); Maison Solutions Inc. (NASDAQ: MSS); and Virtu Financial
Apr 7, 2025 07:30AM P10 Completes Acquisition of Qualitas Funds, a Leading European Lower-Middle Market Alternative Investment Solutions Provider
Apr 7, 2025 07:30AM Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention
Apr 7, 2025 07:30AM Avicanna Announces its 5th Medical Symposium on Cannabinoid-based Medicine
Apr 7, 2025 07:30AM Prime Drink Group Announces Its Intent to Acquire Relax Downlow, The Latest Brand to Collaborate with Lane Hutson
Apr 7, 2025 07:30AM TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals
Apr 7, 2025 07:30AM Q-Gold Announces Appointment of Stan Bharti as Executive Chairman
Apr 7, 2025 07:30AM MariMed Promotes Ryan Crandall to Chief Commercial Officer
Apr 7, 2025 07:30AM Sulliden Acquires Portion of Nickel, Zinc, and Lead Mining Exploration Project in Poland
Apr 7, 2025 07:30AM NFI schedules release of first quarter 2025 financial results and provides details about Annual and Special Meeting of Shareholders
Apr 7, 2025 07:30AM Reunion Neuroscience Presents REKINDLE, a Phase 2 Clinical Trial Evaluating RE104 for the Treatment of Adjustment Disorder (AjD) in Cancer and Other Medical Illnesses at the Anxiety & Depression A
Apr 7, 2025 07:30AM Zevra Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million
Apr 7, 2025 07:30AM Venus Concept to Release First Quarter of Fiscal Year 2025 Financial Results on May 15, 2025
Apr 7, 2025 07:30AM Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors
Apr 7, 2025 07:30AM Bombardier to Report First Quarter 2025 Financial Results and Hold Annual General Meeting of Shareholders on May 1st, 2025
Apr 7, 2025 07:30AM MasterCraft Boat Holdings, Inc. Announces CFO Transition
Apr 7, 2025 07:30AM Reunion Neuroscience Presents REKINDLE, a Phase 2 Clinical Trial Evaluating RE104 for the Treatment of Adjustment Disorder (AjD) in Cancer and Other Medical Illnesses at the Anxiety & Depression Assoc
Apr 7, 2025 07:13AM Correction: Form 8.3 - Octopus Investments - Advanced Medical Solutions Group plc
Apr 7, 2025 07:13AM Top 10 New Tokens on MEXC Average 4,770% Growth in March
Apr 7, 2025 07:11AM Correction: Form 8.3 - Advanced Medical Solutions Group Plc - Octopus Investments
Apr 7, 2025 07:10AM Net Asset Value(s)
Apr 7, 2025 07:05AM Zenas BioPharma Appoints Haley Laken, Ph.D., as Chief Scientific Officer
Apr 7, 2025 07:05AM Kraig Biocraft Laboratories is Happy to Announce its New Director of Molecular Biology as it Accelerates Advanced Fibers Development
Apr 7, 2025 07:03AM Gilat Awarded Up to $23 Million Multi-Year Contract to Service Satellite Transportable Terminal Units for US DoD Customers
Apr 7, 2025 07:01AM FM Capital Announces $240 Million Fund Close – Largest to Date
Apr 7, 2025 07:00AM LG U+ Uses Denodo Platform to Build Modern, Integrated Data Management Infrastructure
Apr 7, 2025 07:00AM Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
Apr 7, 2025 07:00AM Plymouth Industrial REIT Provides Activity Update for First Quarter 2025
Apr 7, 2025 07:00AM Update on Extraordinary General Meeting – Extension of Zijin Put Option and Exclusivity Arrangements
Apr 7, 2025 07:00AM Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity
Apr 7, 2025 07:00AM LG U+ Uses Denodo Platform to Build Modern, Integrated Data Management Infrastructure
Apr 7, 2025 07:00AM Rivalry Announces Evaluation of Strategic Alternatives for Long-Term Growth
Apr 7, 2025 07:00AM ADMA Biologics Statement on Tariffs
Apr 7, 2025 07:00AM iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pi
Apr 7, 2025 07:00AM Castle Biosciences Honored with a Top Workplaces USA Award for Fourth Consecutive Year
Apr 7, 2025 07:00AM Atwater Brewery Releases Atwater Light: Detroit’s Premium Light Craft Beer
View Newer Stories View Older Stories